Predictive Oncology Inc.

NasdaqCM:POAI Stock Report

Market Cap: US$4.8m

Predictive Oncology Balance Sheet Health

Financial Health criteria checks 4/6

Predictive Oncology has a total shareholder equity of $2.0M and total debt of $195.8K, which brings its debt-to-equity ratio to 10%. Its total assets and total liabilities are $7.5M and $5.5M respectively.

Key information

10.0%

Debt to equity ratio

US$195.78k

Debt

Interest coverage ration/a
CashUS$3.08m
EquityUS$1.97m
Total liabilitiesUS$5.53m
Total assetsUS$7.50m

Recent financial health updates

Here's Why We're Watching Predictive Oncology's (NASDAQ:POAI) Cash Burn Situation

Jun 29
Here's Why We're Watching Predictive Oncology's (NASDAQ:POAI) Cash Burn Situation

Recent updates

Here's Why We're Watching Predictive Oncology's (NASDAQ:POAI) Cash Burn Situation

Jun 29
Here's Why We're Watching Predictive Oncology's (NASDAQ:POAI) Cash Burn Situation

Predictive Oncology has a new CEO

Oct 20

Predictive Oncology announces retirement of CEO Mel Engle

Sep 16

Predictive Oncology regains Nasdaq compliance

Feb 02

Financial Position Analysis

Short Term Liabilities: POAI's short term assets ($4.6M) exceed its short term liabilities ($3.8M).

Long Term Liabilities: POAI's short term assets ($4.6M) exceed its long term liabilities ($1.7M).


Debt to Equity History and Analysis

Debt Level: POAI has more cash than its total debt.

Reducing Debt: POAI's debt to equity ratio has reduced from 21.6% to 10% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: POAI has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: POAI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 11.7% each year


Discover healthy companies